揭示上腺素载体的形状选择性调节
Heng Zhang1, Tianwei Zhang2, Dingyan Wang3
1The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Cell
|October 25, 2025
概括
研究人员在上腺素转运体 (NET) 中发现了一个新的基位, 这对于治疗抑郁症和ADHD至关重要. 这一发现揭示了针对NET的药物开发的"门模型".
科学领域:
- 神经科学
- 药理学
- 结构生物学
背景情况:
- 上腺素转运体 (NET) 对于突触神经传递至关重要.
- 网络功能障碍与严重抑郁症和注意力缺陷/多动症 (ADHD) 有关.
- 了解NET的全性调节对于有针对性的治疗开发至关重要.
研究的目的:
- 阐明NET的全性,形状选择性调节.
- 确定NET的新型异质位点和调节机制.
- 为开发下一代NET抑制剂提供结构导向的框架.
主要方法:
- 具有抑制剂的NET复合物的冷电子显微镜 (冷电子显微镜) (莱沃米尔纳西普兰,瓦诺谢林,维拉佐).
- 结构分析以确定结位.
- 虚拟查以发现新的NET抑制剂.
- 在体外和体内验证已识别的抑制剂.
主要成果:
- 在NET的内部前厅内确定了一个以前未被定义的全位.
- 提出了一种"型",解释了形状选择性抑制剂的结合.
- 发现了具有强大的NET抑制活性的新兴抑制剂.
- 在临床前模型中证明已确定的抑制剂的抗抑郁作用.
结论:
- 已识别的全位和"型"为NET调节提供了机制框架.
- 结构导向的洞察力有助于开发针对神经精神疾病的治疗方法.
- 这项工作有助于进一步了解下一代抗抑郁药的NET度调节.
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
Adrenergic Neurons: Neurotransmission
5.1K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
5.1K
Adrenergic Receptors: β Subtype
3.5K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.5K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K
Adrenergic Receptors: ɑ Subtype
2.7K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.7K
Adrenergic Receptors (Adrenoceptors): Classification
4.6K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
4.6K


